These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20800520)

  • 21. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of high-throughput ADME in drug discovery.
    Kassel DB
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chem-tox informatics: data mining using a medicinal chemistry building block approach.
    Johnson DE; Blower PE; Myatt GJ; Wolfgang GH
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):92-101. PubMed ID: 11727328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SAR by ILOEs: an NMR-based approach to reverse chemical genetics.
    Becattini B; Pellecchia M
    Chemistry; 2006 Mar; 12(10):2658-62. PubMed ID: 16121405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of microarrayed compound screening.
    Hoever M; Zbinden P
    Drug Discov Today; 2004 Apr; 9(8):358-65. PubMed ID: 15081963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of microwave synthesis on drug discovery.
    Kappe CO; Dallinger D
    Nat Rev Drug Discov; 2006 Jan; 5(1):51-63. PubMed ID: 16374514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling of activity landscapes for drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
    Cohen C; Fischel O; Cohen E
    Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bioanalytics in medicinal chemistry: from assay development to evolutive drug design].
    Jose J
    Ann Pharm Fr; 2009 Nov; 67(6):399-407. PubMed ID: 19900603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular recognition: the fragment approach in lead generation.
    Fattori D
    Drug Discov Today; 2004 Mar; 9(5):229-38. PubMed ID: 14980541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target family-directed exploration of scaffolds with different SAR profiles.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What do medicinal chemists actually make? A 50-year retrospective.
    Walters WP; Green J; Weiss JR; Murcko MA
    J Med Chem; 2011 Oct; 54(19):6405-16. PubMed ID: 21755928
    [No Abstract]   [Full Text] [Related]  

  • 38. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting key example compounds in competitors' patent applications using structural information alone.
    Hattori K; Wakabayashi H; Tamaki K
    J Chem Inf Model; 2008 Jan; 48(1):135-42. PubMed ID: 18177028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective optimization of side activities: the SOSA approach.
    Wermuth CG
    Drug Discov Today; 2006 Feb; 11(3-4):160-4. PubMed ID: 16533714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.